Waldencast (WALD) Expected to Announce Earnings on Tuesday

Waldencast (NASDAQ:WALDGet Free Report) is projected to issue its quarterly earnings data after the market closes on Tuesday, March 18th. Analysts expect the company to announce earnings of ($0.07) per share and revenue of $70.43 million for the quarter. Parties interested in listening to the company’s conference call can do so using this link.

Waldencast Stock Up 3.5 %

NASDAQ:WALD opened at $3.21 on Monday. The company has a debt-to-equity ratio of 0.21, a quick ratio of 0.78 and a current ratio of 1.47. The firm has a fifty day simple moving average of $3.24 and a two-hundred day simple moving average of $3.47. Waldencast has a 12 month low of $2.41 and a 12 month high of $7.54.

Wall Street Analysts Forecast Growth

WALD has been the subject of a number of analyst reports. Telsey Advisory Group reiterated an “outperform” rating and set a $6.00 price objective on shares of Waldencast in a report on Tuesday, March 11th. DA Davidson boosted their price target on shares of Waldencast from $7.25 to $7.50 and gave the stock a “buy” rating in a report on Wednesday, December 4th. TD Cowen started coverage on shares of Waldencast in a report on Monday, December 16th. They set a “hold” rating and a $4.30 price target on the stock. Finally, Canaccord Genuity Group boosted their price target on shares of Waldencast from $5.00 to $6.00 and gave the stock a “buy” rating in a report on Friday, November 22nd. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat.com, Waldencast currently has a consensus rating of “Moderate Buy” and a consensus target price of $5.76.

Read Our Latest Research Report on WALD

About Waldencast

(Get Free Report)

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.

Further Reading

Receive News & Ratings for Waldencast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waldencast and related companies with MarketBeat.com's FREE daily email newsletter.